Fritextsökning
Innehållstyper
-
Pfizer lays a chunky bid on Wyeth
The merger of two pharma giants is the largest industry deal so far this year. Pfizer will acquire Wyeth in a cash-and-stock transaction currently valued at app...
-
First ever study of human stem cell treatment
The FDA says yes to the world's first study in man of a human embryonic stem cell based therapy to treat spinal injury.
-
Prenatal testing breakthrough
For the first time specific gene expression information from fetal cells isolated from maternal blood samples is available.
-
Control of blood vessels can treat obesity
Mice exposed to low temperatures develop more blood vessels in their adipose tissue and metabolise body fat more quickly, according to a new study from Karolinska Institutet.
-
Ten recieve the Venture Cup West Prize
At this year´s Venture Cup West awards the 10 best business ideas in Venture Cup West 08/09 were chosen, receiving SEK 10 000 each.
-
Nordisk VD för ZEISS lämnar över stafettpinnen
Walther Heger, Managing Director för ZEISS Nordics sedan 28 år, har beslutat sig för att avsluta en imponerande karriär. I slutet av september kommer Walther He...
-
Transatlantic cooperation for healthier food
Danish and American scientists are going to work together to find ways to fight malnutrition and life style disease like obesity in the western world.
-
Transatlantic cooperation for healthier food
Danish and American scientists are going to work together to find ways to fight malnutrition and life style disease like obesity in the western world.
-
Density meters with six-digit precision
The new instruments from Krüss Optronic offer high sensitivity for density measurements.
-
Welcome to wonderful Copenhagen
Strategically located, the Danish capital is the focal point of one of the most dynamic regions in Northern Europe. Here are some tips on where to spend your ti...
-
Mingling types - who to aim for and who to avoid:
Read about different mingling types - who are you?
-
Topplista innovationer: Ögonbehandling blev fjäder i hatten för Pharmacia
Från komplicerad och ibland riskabel operation till rutinåtgärd. Pharmacias injektionsvätska Healon blev omvälvande för ögonkirurgin.
-
Almatec Biocore för hygieniska och sterila applikationer
Aseptiska pumpar med FDA, EHEDG, 3-A, USP Class VI, EC 1935 och ATEX godkännanden.
-
Rapid and thorough homogenization of samples
MP Biomedicals presents the Fasprep-24 instrument, a new high-throughput model of the earlier Bio 101 Systems Fastprep homogenizer.
-
Studie: Malaysisk blomma har cancerdödande egenskaper
Växtarten Tabernaemontana corymbosa blommar året om, är frosttolerant och gillar sol till måttlig skugga men trivs som bäst i djungeln i sydöstra Asien. Den pro...
-
Ny kontrollenhet med IO-Link samlar analoga givarsignaler
SMC lanserar en ny kontrollenhet för upp till 4 givare och med möjlighet att mäta två olika differenstryck. Kontrollenheten har tydlig, tredelad display och kom...
-
Reidar Rasmussen, Labmodul
Why are you going to Scanlab and Biotech Forum?
-
Cancer cells cheat suicide call
Cancer cells cheat death by reversing a process which causes normal cells to commit suicide at the end of their natural life, researchers from the University of...
-
Diagnostics to deal with new diseases
Maria Brytting at the Swedish Institute for Infectious Disease Control, SMI, will share her experiences from April 2009 when the new influenza A virus, H1N1, wa...
-
Success fee to Bioinvent and partner
The cancer collaboration started last year. After successful technology transfer the two partner companies now receives 5 million euro from pharma giant Roche.
-
Oasmia gets a confirmation
FDA has granted Oasmia an expedited review status for Paclical Vet.
-
Hey Johannes Hedman...
... graduate of SKL and LTH, who has improved a method of forensic analysis
-
Next generation sequencer in an accessible format
The GS Junior System is a new benchtop-sized next generation sequencing platform.
-
Early stage research and low turnaround dominates
Nordic science parks are full of advanced research performed by small companies but little research is done in later stages. Only a couple of the best performer...
BREAKING